EUVIMEDEUVIMED entdecken
Crossref

Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participants

Anh B Lam, Andrea Pelletier, Sienna M Durbin, Kaitlyn Lynch, Laura A Petrillo, Rachel Jimenez, Mary Boulanger, Cynthia Moore, Leah Thompson, Viola Bame, Vaishnavi Yalala, Nicholas Ollila und 5 weitere

Supportive Care in Cancer · 2026-07 · 34 (7)

DOI: 10.1007/s00520-026-10869-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 11.06.2026. Verfasst von Anh B Lam und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Neoplasms, Quality of Life. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Individuals with cancer often endure a substantial symptom burden. However, little is known about the symptom burden of patients with cancer participating in early phase cancer clinical trials (EPCT). METHODS: We prospectively enrolled adults with cancer participating in EPCTs at Massachusetts General Hospital from 4/2021-1/2023. Participants completed surveys prior to EPCT initiation that assessed symptoms (Edmonton Symptom Assessment System [ESAS]), quality of life (QOL; Functional Assessment of Cancer Therapy-General), depression/anxiety symptoms (Patient Health Questionnaire-4), and financial well-being (COST). We used regression models to explore associations of symptom burden with patient-reported outcomes and clinical outcomes. RESULTS: Among 195 patients enrolled, 185 participants completed the surveys (94.9% response rate). Participants had a median age of 63.5 years (range: 31.8-88.6) and 57.3% were female. Most common cancer types were gastrointestinal and breast. Median survival was 7.82 (IQR: 3.88-18.71) months, and median follow-up time was 12.20 (IQR: 7.99-16.80) months. Participants reported moderate/severe fatigue (51.7%), poor well-being (49.7%), drowsiness (36.2%), pain (26.4%), and lack of appetite (25.8%). Higher ESAS-total scores and greater number of moderate/severe symptoms were associated with lower QOL, increased depression/anxiety symptoms, and worse financial well-being (p-values < 0.05 for all). Higher ESAS-total scores (HR:1.02, p < 0.001) were associated with worse overall survival. CONCLUSION: Among EPCT participants, higher symptom burden at time of clinical trial initiation correlated with decreased QOL, increased depression/anxiety symptoms, worse financial well-being, shorter time on trial, and worse overall survival. Interventions seeking to enhance care delivery and outcomes for EPCT participants should strive to address the symptom burden of this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Reported Outcome MeasuresNeoplasmsQuality of LifeHumansFemaleSymptom BurdenAgedMiddle AgedProspective StudiesAdultMaleAged, 80 and overDepressionAnxietySurveys and QuestionnairesClinical Trials as TopicFatigue

Stichwörter der Autor:innen

Clinical outcomesEarly phase clinical trialsPatient-reported outcomesSymptom burden

Autor:innen und Institutionen

  • Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Brigham & Women's Hospital, Boston, MA, USA.
  • Division of Hematology & Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Termeer Center for Targeted Therapies, Massachusetts General Hospital, Boston, MA, USA.
  • Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.

Zitieren

APA

Lam, A. B., Pelletier, A., Durbin, S. M., Lynch, K., Petrillo, L. A., Jimenez, R., Boulanger, M., Moore, C., Thompson, L., Bame, V., Yalala, V., Ollila, N., Malowitz, B., McIntyre, C., Juric, D., Lundquist, D., & Nipp, R. D. (2026). Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participants. Supportive Care in Cancer, 34(7). https://doi.org/10.1007/s00520-026-10869-7

Vancouver

Lam AB, Pelletier A, Durbin SM, Lynch K, Petrillo LA, Jimenez R, et al. Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participants. Supportive Care in Cancer. 2026;34(7). doi:10.1007/s00520-026-10869-7

BibTeX
@article{Lam2026,
  author = {Lam, Anh B and Pelletier, Andrea and Durbin, Sienna M and Lynch, Kaitlyn and Petrillo, Laura A and Jimenez, Rachel and Boulanger, Mary and Moore, Cynthia and Thompson, Leah and Bame, Viola and Yalala, Vaishnavi and Ollila, Nicholas and Malowitz, Benjamin and McIntyre, Casandra and Juric, Dejan and Lundquist, Debra and Nipp, Ryan David},
  title = {Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participants},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {7},
  doi = {10.1007/s00520-026-10869-7}
}
Kostenlos starten →